P ressure autoregulation in the healthy or diseased brain has been extensively studied since the earli est descriptions of the response of cerebral vessels to changes in BP. 15, 27 Autoregulation is an important neu roprotective mechanism that varies pial arteriolar caliber when BP changes to maintain a (relatively) constant CBF. Normally, autoregulation is active within a MABP range of 50-150 mm Hg, 34 and responds within seconds of the BP change. 32 However, autoregulation may be impaired after TBI, and several studies suggest that this impair ment is a predictor of outcome in TBI. Object. Cerebral pressure autoregulation is an important neuroprotective mechanism that stabilizes cerebral blood flow when blood pressure (BP) changes. In this study the authors examined the association between autoregulation and clinical factors, BP, intracranial pressure (ICP), brain tissue oxygen tension (PbtO 2 ), and outcome after pediatric severe traumatic brain injury (TBI). In particular we examined how the status of autoregulation influenced the effect of BP changes on ICP and PbtO 2 .
Significant advances in the management of TBI have occurred through improved understanding of cerebral physiology including CBF, ICP, and PbtO 2 among others. However, these monitored variables may be influenced by interpatient heterogeneity in autoregulation; that is, the responses of CBF, CBV, ICP, and PbtO 2 to BP changes may not always be predictable. This heterogeneity in TBI is important. First, maintenance of CPP at both higher and lower levels has been recommended. 31, 37, 38 However, if autoregulation is impaired, high CPP may increase ICP (by increased CBV and possibly vasogenic edema) and low CPP may increase the risk of secondary ischemia within a range of BP that would have normally been con sidered acceptable. Despite this, the status of autoregu lation in individual patients is generally not considered in current recommendations for optimal CPP. 3, 5 Second, several studies show an association between impaired autoregulation and poor outcome in adult and pediatric TBI. 10, 18, 33, 40, 49 However, whether impaired autoregulation increases secondary insults and therefore represents a po tential therapeutic target that influences outcome is not clear. Third, there are data to suggest that the status of autoregulation may influence the choice of ICP-or CPPdirected treatment, which currently are the foundation of TBI care. 20 Although the importance of autoregulation in the pathophysiology of pediatric TBI is increasingly appreci ated, there are limited studies that have formally tested autoregulation. In particular, the impact of autoregulation on physiological parameters such as ICP and PbtO 2 in pe diatric TBI is only beginning to be elucidated. Therefore, in this study of 24 children with severe TBI we examined: 1) the association between impaired autoregulation and clinical factors including the GCS score, ICP, and PbtO 2 ; 2) how autoregulation influenced the response of ICP and PbtO 2 to BP changes; and 3) the relationship between au toregulation and outcome.
Methods
Approval for the study was obtained from the institu tional review boards of the University of Cape Town and the Red Cross War Memorial Children's Hospital. Patient consent was obtained from the nearest relative for inclu sion in the study.
Patient Selection
This study was a part of a larger prospective obser vational study of intracranial monitoring in children with TBI. We collected data from all consecutive children (age < 15 years old) with severe TBI (GCS score ≤ 8) who used ICP and PbtO 2 monitors and who underwent auto regulation testing between June 2006 and May 2008. We tested autoregulation as part of routine clinical treatment of patients, and information from these tests was used to assist in making clinical decisions about BP management. Patients were selected for testing based on the need for additional information about the relationship between BP and ICP and when expertise for testing was available (in the context of a busy practice). Therefore, we were not able to perform autoregulation testing in all consecutive patients. Also, we did not test autoregulation in patients who had ICP (> 25 mm Hg) or BP instability.
Intracranial Pressure and PbtO 2 Monitors
Intracranial pressure was measured using a ventriculos tomy or an intraparenchymal monitor (ICP Express, Cod man; or Camino, Integra Neurosciences). When an ICP monitor was placed, we also monitored and treated PbtO 2 . Brain tissue oxygen tension monitors (Licox, Integra Neu rosciences) were inserted into normalappearing right fron tal white matter if there were no localized lesions, or in the hemisphere with the greater swelling or containing focal lesions. The position of the monitor was confirmed using a followup head CT scan. Data from patients were collected for analysis after allowing for a 2hour runin period to avoid potential artifactual data from a stabilizing catheter.
Patient Care
In general, patient care at our institution is based on the current recommendations for the management of severe TBI in children. [1] [2] [3] Briefly, all patients are resus citated on admission, undergo immediate evacuation of spaceoccupying lesions when present, and are intubated and mechanically ventilated in the pediatric ICU. Elevat ed ICP is treated using a stepwise approach when ICP is > 20 mm Hg according to the guidelines for ICP manage ment in children. 1, 2 We aim to keep CPP > 50 mm Hg in children > 2 years old, and > 45 mm Hg in children < 2 years old. In addition, PbtO 2 is monitored. Compromised (low) PbtO 2 is defined as < 20 mm Hg and is treated us ing a hierarchical treatment algorithm beginning with a search for a possible cause for low PbtO 2 . Further details of our ICP and PbtO 2 management are described else where. 14 
Protocol for Autoregulation Testing
Transcranial Doppler ultrasonography monitoring was used to examine autoregulation, similar to the method described by Vavilala et al., 48 in which a titrated infusion of phenylephrine is used to increase MABP by 20% of its baseline value. Before testing, baseline recordings were made of MABP, ICP, PbtO 2 , and mean FV MCA . Blood FV M CA was recorded using a TCD machine (Smartlite, Rimed). Although both sides were assessed in most patients, only recordings obtained from hemispheres ipsilateral to the ICP and PbtO 2 monitors were analyzed. We did not rou tinely test autoregulation bilaterally. When the MABP in crease reached 20% of its baseline value, the ICP, PbtO 2 , and FV MCA recordings were repeated. Thereafter, MABP was returned to its baseline value and recordings were re peated for a final time. Testing was only performed when PaCO 2 was between 30 and 45 mm Hg and only tests in which all physiological data were available were used for analysis. All TCD studies were performed by 1 examiner (A.A.F.) who was experienced in the use of TCD.
An ARI was calculated based on the FV MCA response to increased MABP. 32 The equation used to calculate ARI was: ARI = %∆eCVR / %∆MABP or %∆CPP, in which eCVR is the estimated CVR and is calculated as MABP/FV. The changes (∆) in eCVR and CPP were calculated as the difference between the values at baseline and after elevation of MABP. Because the slope of the CBF response to a change in BP is not perfectly 0, even when autoregulation is intact, it is more accurate to take into ac count the change in BP encountered than just the absolute change in FV, and to calculate the change in CVR as a response to that BP change. This method produces a bet ter estimate of the ability of the vascular bed to react to changes in BP, as CVR is the effector of autoregulation. 32 An ARI value of 1 implies that the strength of autoregu lation is maximal, a value of 0 implies complete absence of autoregulation, and values between 0 and 1 reflect the relative strength of autoregulation; that is, higher ARI val ues imply a better cerebrovascular resistance response and therefore stronger autoregulation, whereas a low vascular resistance response implies a pressurepassive relationship between BP and FV. Although the autoregulation capacity is a continuum, an ARI value of 0.4 is commonly used as a threshold to describe whether autoregulation is intact or not. Values for ARI < 0.4 are typically associated with im paired autoregulation and values ≥ 0.4 are associated with intact autoregulation.
42,45,48

General Data Collection
In addition to the physiological data recorded during testing, we also recorded several clinical factors, includ ing the mechanism of injury, postresuscitation GCS score, initial MABP, ISS score, PTS, 43 PIM2 score, 39 whether the head injury was isolated or part of polytrauma, CT clas sification according to the Marshall criteria, 29 whether the brain injury was focal or diffuse, episodes of prehospital hypoxia and hypotension (systolic blood pressure < the fifth centile for age), highest ICP experienced, mean ICP and PbtO 2 for the first 24 hours of monitoring and for the full duration of monitoring, and whether the test was conducted after DCH.
Outcome
Outcome was assessed by the GOS score as an ordi nal score and dichotomized to unfavorable (1 = death, 2 = vegetative, and 3 = severe disability) and favorable (4 = mild disability, 5 = minor or no disability) outcome. Clinical outcome of survivors was assessed from follow up clinical visits that included assessments by neurosur geons, occupational therapists, speech therapists, pediat ric developmental specialists, and school progress reports (where appropriate) 6 months after injury.
Statistical Analysis
All data were analyzed using R statistical computing (http://www.rproject.org) and Stata software (version 7.0, Stata Corp.). Results are reported as means ± SD or me dian and IQR depending on distribution characteristics. Significance was set at a p value of 0.05. Variables were tested for normality with the Shapiro-Wilk test. Spear man and Pearson correlation coefficients were used to test correlations between the ARI and: 1) demographic and clinical factors; 2) baseline physiological factors at the time of testing (MABP, ICP, CPP, and PbtO 2 ); and 3) the change in physiological factors with testing (∆MABP, ∆ICP, and ∆PbtO 2 ). Linear regression was used to exam ine testrelated factors against the ARI as a continuous variable, and logistic regression was used to examine fac tors against dichotomized ARI (< 0.4 and ≥ 0.4). Factors significant in univariate analyses were then tested in mul tivariate analyses.
The ARI (as a continuous and dichotomous factor) was also tested against the GOS score as a dichotomous variable with logistic regression (a GOS Score 1-3 was defined as unfavorable outcome, and a GOS Score 4-5 as favorable outcome), and as an ordinal score (GOS Score 1-5) with a proportional odds regression model. When testing for associations between the ARI and outcome, only the worst ARI for each patient was used.
Results
Clinical Characteristics
Fiftytwo autoregulation tests for which all data were available were performed in 24 patients with severe TBI. Clinical and physiological characteristics are summa rized in Tables 1 and 2 , respectively. Sixteen tests (31%) were performed within the first 24 hours of injury. Four children (17%) had autoregulation tested once during their stay in the ICU; all others had autoregulation tested twice or more. Autoregulation was impaired (ARI < 0.4) in 7 (29%) of 24 patients at some point during their ICU stay. No patients in this cohort had mass lesions requiring craniotomy. However, DCH was performed for diffuse brain swelling and medically refractory elevated ICP in 2 patients; 5 of the autoregulation tests were performed on these patients after surgery. Table 3 summarizes the relationships between clini cal factors and ARI. Only initial GCS score demonstrated a significant relationship (see below). There was a nonsig nificant trend toward lower ARI values for patients who had received DCH (p = 0.07); however, these account ed for tests in only 2 patients. There was also a nonsig nificant trend toward an association with ISS score (p = 0.08). Table 4 summarizes baseline physiological factors before testing. Table 5 shows the linear regression results for ARI as a continuous variable and factors related to the tests. The ∆ICP and ∆PbtO 2 variables were inversely associated with the strength of autoregulation (see below). Table 6 shows the differences between physiological fac tors at testing for tests of patients with impaired (ARI < 0.4) and intact (ARI ≥ 0.4) autoregulation. Baseline val ues for ICP, PbtO 2 , the ratio of PbtO 2 /PaO 2 , MABP and FV MCA were similar in the patients with impaired or intact ARI. There was no association between ARI and time af ter injury (p = 0.97). The change in ∆ICP was not related to ∆MABP (p = 0.54).
Comparison of the ARI With Clinical and Physiological Factors
Initial GCS Score and ARI
The initial GCS score was significantly associated with the ARI (p = 0.02, r = 0.32). Specifically, patients with an initial GCS score of 3 were more likely to have a low ARI. Baseline FV MCA , baseline ICP, and age were included in the multivariate regression model because of clinical relevance. Initial GCS score was an independent predictor of ARI in the multivariate analysis (p = 0.03, R 2 = 0.002). The binary point of best discrimination for initial GCS score was an ARI of 0.68 (p = 0.01). 
Intracranial Pressure and the ARI
There was an inverse relationship between the ARI (continuous and dichotomous) and ∆ICP (continuous ARI, p = 0.005, r = −0.4); that is, higher ARI values were associated with no ICP change or a reduction in ICP when BP was increased (consistent with the description in adult patients of pressureactive and pressurestable responses with intact autoregulation 25 ), whereas lower ARI values were associated with increased ICP (Tables 5 and 6 ). When the ARI was ≥ 0.4, ICP increased with testing in 4 (9%) of 43 tests, whereas there was no increase or a re duction in ICP in 39 (91%) of 43 tests. When the ARI was < 0.4, ICP increased in 7 (78%) of 9 tests, and decreased in 2 (22%) of 9 tests.
Brain Tissue Oxygen Tension and the ARI
The ARI (continuous and dichotomous) was inverse ly associated with ∆PbtO 2 (continuous ARI, p = 0.002, r = −0.5). However, the relationship between changes in PbtO 2 and the dichotomized ARI categories was less evi dent than was the case for ICP. Brain tissue O 2 tension in creased in most cases when BP was increased even when autoregulation appeared to be intact (by dichotomized categories) or ARI was relatively high; however, the mag nitude of this response was still related to the strength of the ARI (Tables 5 and 6 ). When the ARI was ≥ 0.4, PbtO 2 increased with testing in 30 (70%) of 43 tests, whereas there was no increase or a reduction in PbtO 2 in 13 (30%) of 43 tests. When the ARI was < 0.4, PbtO 2 increased in all 9 tests (100%). When compared with the tests in which ARI was ≥ 0.4 and ICP decreased or remained unchanged, PbtO 2 still increased in most cases (26 [67%] of 39 tests). Figure 1 shows the changes in ICP, PbtO 2 , and estimated CVR during testing in 2 patients-one with impaired au toregulation and the other with intact autoregulation.
The ARI and Outcome
The relationship between ARI and outcome was ex plored in several ways, using combinations of ARI as the independent continuous and dichotomous variable, and outcome (GOS score) as the dependent ordinal and dichot omous variable. No relationship between the ARI and out come was found (p value range 0.243-0.662).
Discussion
In this study we examined associations between mea surements of pressure autoregulation (determined by the TCD-detected FV MCA response to increased BP) and clini cal and physiological factors in 24 children between 1 and 11 years old with severe TBI. The ARI was calculated as an index of the strength of autoregulation. 32 The main findings of this study were: 1) impaired autoregulation was observed in 29% of patients; 2) low ARI (weak auto regulation) was more common when the initial GCS score was low, but no other clinical factors were associated with autoregulation status; 3) when autoregulation is impaired (ARI < 0.4), ICP increases when BP is increased; 4) when autoregulation was intact (ARI ≥ 0.4) or relatively strong, ICP usually remained unchanged or decreased when BP was increased; 5) PbtO 2 increased when BP was increased in most patients, even when the ARI was relatively high (stronger autoregulation), but the magnitude of this re sponse remained associated with the ARI; and 6) the ARI and outcome were not significantly related. There was a nonsignificant trend toward an association of the ARI with increased injury severity and DCH that suggests further study would be helpful, in particular to examine the effect of DCH on autoregulation in a larger group of patients. In general, our findings demonstrate the variable response of ICP and PbtO 2 to BP changes in individual patients with TBI. Autoregulation testing may reveal some of this vari ability and may help to better define optimal BP and CPP targets in individual patients. This variability of the ICP and PbtO 2 response may also caution against universal CPP recommendations for all patients with TBI.
Methodological Limitations
There are several potential methodological limita tions to this study. First, our sample size (24 patients) is small, although 52 autoregulation measurements were ob tained; therefore, the results should be regarded as prelim inary. However, our sample size compares favorably with sample sizes of other autoregulation studies. 11, 16, 26, 30, 40, 42, 44 Second, autoregulation testing was not performed on ev ery patient. In particular, it was not performed on patients who died within the first 24 hours, and patients who were hemodynamically unstable or had unstable ICP. There fore, this factor may underestimate the true prevalence of impaired autoregulation and affect the generalizability of the results. Third, the time of testing was variable and it was not performed every day. Temporal heterogeneity of autoregulation may influence our results, as may spa tial heterogeneity, because we did not test autoregulation bilaterally in all patients. Fourth, we cannot exclude the possibility that phenylephrine may have direct cerebro vascular effects. However, phenylephrine appears to have minimal direct effects on cerebral blood vessels 7, 23 and is the preferred agent for autoregulation testing. 4, 17, 19, 25, 45 Fifth, we cannot exclude the possibility that longer peri ods at a higher BP may have other cerebrovascular con sequences. 13 Finally, we did not test autoregulation across the full physiological range of the autoregulatory plateau. Therefore, patients with intact autoregulation on testing may have responded differently at other MABP intervals or over a larger range of MABP. However, autoregula tion testing was used in this study as a pragmatic guide to gain information about the intracranial dynamics over a range of increased MABPs that the individual patient may experience spontaneously or that clinicians may use to improve PbtO 2 . Despite these potential limitations, the results of this study confirm the association of impaired autoregulation with low initial GCS score, and demon strate the inverse relationship between the strength of the autoregulation and the change in ICP and PbtO 2 when BP is increased.
The ARI and Baseline Variables
In the present study, the ARI was not associated with baseline ICP. In part this may have been influenced by the fact that the ICP at testing usually was < 20 mm Hg. How ever, the mean ARI was similar in patients with and with out ICP ≥ 20 mm Hg (ARI 0.76 for both). Further study of autoregulation when ICP is elevated in children would be helpful because elevated ICP has been reported to adversely affect autoregulation in adult patients. 9, 11 Others have sug gested that children who have hyperemia (based on TCD) are more likely to have impaired autoregulation. 48 Howev er, we were unable to demonstrate this in the present study. The mean ARI was 0.76 for patients with FV MCA ≥ 120 cm/ second and 0.77 when FV MCA was < 120 cm/second. The diagnosis of hyperemia in children with TBI is not precise. Normal values for CBF depend on age and sex, 24, 50 and in appropriately low CBF strictly should only be diagnosed when CBF is lower than normative ranges for age and sex, and when the relationship between CBF and metabolism is known. Therefore, TCD-derived absolute values of FV may not be adequate to demonstrate a relationship between impaired autoregulation and true hyperemia.
Response of ICP to Elevated BP
In theory, CBV and ICP changes vary inversely with BP within the active range of autoregulation due to modi fication of small arterioles (diameter ~ 200 µm), which can undergo diameter changes of 200% 23 and are suffi cient to alter ICP. 47 The findings of the present study sup port this contention. Rosner et al. 37, 38 proposed that CPP be maintained at higher levels to manage ICP by avoid ing the vasodilatory cascade associated with lower CPP. Nevertheless, autoregulation often is impaired and if so, this approach will increase CBF and CBV (and possibly lead to a later increase in vasogenic edema) and therefore increase ICP. The early increase of ICP in response to increased BP when autoregulation is impaired is demon strated in the present study. However, in a small proportion of cases (9%), the response of ICP was unexpected; that is, there was an increase in ICP even when autoregulation was believed to be intact. There are several possible expla nations for this difference. First, during the time required for testing there may have been spontaneous ICP fluctua tions unrelated to the test. Second, although the threshold for definition of impaired versus intact autoregulation (an ARI threshold of 0.4) may be useful, it remains artificial and imprecise. Others have used different thresholds. 26 The strength of autoregulation is a continuum, though; therefore, only an ARI of 0 implies completely absent autoregulation. However, a maximal ARI (an ARI near or equal to 1) is expected in healthy individuals and a re duced ARI is associated with decreasing autoregulatory capacity in individuals with head injuries. Despite this lack of specificity, our results demonstrate the increased risk of elevated ICP when BP is increased in pediatric patients with TBI and poor autoregulatory capacity.
Response of PbtO 2 to Elevated BP
Several studies of adult TBI have examined the rela tionship between CPP and PbtO 2 . 6, 8, 12, 22, 28, 36, 41, 46 The data are conflicting, but in general suggest that PbtO 2 increases when CPP is increased. However, most of these studies did not test autoregulation. Few human studies have di rectly measured the relationship between autoregulation and PbtO 2 . Jaeger et al. 21 reported a close association be tween PbtO 2 changes and autoregulation status that was determined by observation of the relationship between ICP and spontaneous fluctuations in BP. Lang et al. 26 formally tested autoregulation (with TCD) and the PbtO 2 response to increased BP in 14 adult patients. The authors suggested that the PbtO 2 response to BP may be useful in the inter pretation of autoregulation. However, they also showed an increase of PbtO 2 in 92% of their cases when BP was increased, as well as a closer relationship between auto regulation and ICP than between autoregulation and PbtO 2 . These data agree with our finding that PbtO 2 , although as sociated with the ARI, often increased despite FV MCA re sults that implied intact, or relatively preserved, autoregu lation, suggesting that local regulatory mechanisms may be impaired even when global autoregulation is intact or that there is a local effect of phenylephrine. A local disturbance of regulatory mechanisms may be particularly prevalent in pericontusional locations. 34 Others have also reported less predictable changes in PbtO 2 based on autoregulation pro file. 35 Therefore, the PbtO 2 response to BP changes may re flect local mechanisms, or mechanisms not yet determined, as much as it does hemispheric autoregulatory capacity.
Autoregulation and Outcome
We did not observe an association between autoregu lation and outcome in this study, unlike others. 10, 18, 33, 40, 49 A possible explanation is that the timing of testing in our study was variable and the most severely injured patients may not have been tested. However, this also may have occurred in other studies that show a relationship between autoregulation and outcome. An alternative explanationbecause we also used autoregulation to guide therapy-is that results from testing may have confounded the asso ciation with outcome. This is important because it is still unclear whether impaired autoregulation leads to second ary insults that worsen outcome; therefore, the possibility that appropriate responses to the status of autoregulation may influence outcome, and autoregulation may be used as a "therapeutic target," warrant further study.
Conclusions
The key practical issues from this study are: 1) au toregulation is variable in children with severe TBI; 2) this is not predictable by clinical characteristics without measurement; 3) whether autoregulation is intact is im portant because it has a significant impact on the changes in an individual patient in ICP and brain O 2 for a given change in BP; and 4) the status of autoregulation should be considered when we set individual BP targets for pa tients with TBI. Impaired autoregulation was associated with increased ICP when BP was increased. The PbtO 2 response to increased BP was also inversely related to the autoregulatory capacity but usually increased even when autoregulation appeared to be relatively strong, which may reflect impaired local tissue regulatory mechanisms. For centers in which it is not possible to measure FV or CBF responses to changes in BP, it appears reasonable to suggest that the response of ICP to induced changes in BP, although not precise, may be used as a surrogate marker of the strength of autoregulation in most cases.
